The clinical performance is complex and often involves multi-system congestion. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PML-associated therapies require individualized development, typically including multidimensional management, including drug therapy, rehabilitation interventions, and regular follow-up visits. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many of the neural system disorders that have been difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of symptoms associated with PML. The platform serves a team of domestic and foreign experts in the field of neural systems related to the China International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.